INCREASING IN THE CASUISTRY OF ETIOLOGICAL TREATMENT BENEFITS IN CHRONIC CHAGAS DISEASE PATIENTS FROM EPIDEMIOLOGICAL SURVEILLANCE AREA IN SOUTHERN BRAZIL